Cargando…
Proliferative Tumor Doubling Times of Prostatic Carcinoma
Prostate cancer (PCa) has a variable biology ranging from latent cancer to extremely aggressive tumors. Proliferative activities of cancers may indicate their biological potential. A flow cytometric assay to calculate maximum proliferative doubling times (T (max)) of PCa in radical prostatectomy spe...
Autores principales: | Werahera, Priya N., Glode, L. Michael, La Rosa, Francisco G., Lucia, M. Scott, Crawford, E. David, Easterday, Kenneth, Sullivan, Holly T., Sidhu, Rameshwar S., Genova, Elizabeth, Hedlund, Tammy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196972/ https://www.ncbi.nlm.nih.gov/pubmed/22096656 http://dx.doi.org/10.1155/2011/301850 |
Ejemplares similares
-
Carcinoid tumor of the verumontanum (colliculus seminalis) of the prostatic urethra with a coexisting prostatic adenocarcinoma: a case report
por: Smith, Maxwell, et al.
Publicado: (2010) -
Phase II Study of Pomalidomide in Patients with Castration-Resistant Prostate Cancer
por: Amato, Robert J., et al.
Publicado: (2011) -
The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation
por: Tang, Xi-Yang, et al.
Publicado: (2022) -
Differences in proliferative activity of rat and human prostate in culture.
por: Shipman, P. A., et al.
Publicado: (1975) -
Targeted Therapy for Metastatic Renal Carcinoma: an Update
por: da Silva, Rodrigo Donalisio, et al.
Publicado: (2014)